A critical role for virus-specific CD8+ CTLs in protection from Theiler's virus-induced demyelination in disease-susceptible SJL mice

Virology

Volumn 402, Issue 1, 2010, Pages 102-111

  Getts, Meghann Teague ^a   Richards, Maureen H ^a   Miller, Stephen D ^a  

^a NORTHWESTERN UNIVERSITY   (United States)

Author keywords

Cytotoxic T lymphocytes; Disease susceptibility; Mutliple sclerosis; Theiler's murine encephalomyelitis virus; Viral epitopes

Indexed keywords

EPITOPE; MYELIN;

ADOPTIVE TRANSFER; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; AUTOIMMUNE DISEASE; CD8+ T LYMPHOCYTE; CELL ISOLATION; CELLULAR IMMUNITY; CENTRAL NERVOUS SYSTEM INFECTION; CONTROLLED STUDY; CYTOLYSIS; CYTOTOXIC T LYMPHOCYTE; DELAYED HYPERSENSITIVITY; DEMYELINATION; DISEASE PREDISPOSITION; ENZYME LINKED IMMUNOSPOT ASSAY; HISTOLOGY; IMMUNOHISTOCHEMISTRY; IN VIVO STUDY; LIVER; LUNG; MOUSE; MULTIPLE SCLEROSIS; MURINE ENCEPHALOMYELITIS VIRUS; NONHUMAN; PRIORITY JOURNAL; VIRUS INFECTION; VIRUS LOAD; ANIMAL; ANIMAL DISEASE; CARDIOVIRUS INFECTION; DEMYELINATING DISEASE; IMMUNOLOGY; VIROLOGY;

MUS; THEILER'S ENCEPHALOMYELITIS VIRUS;

ADOPTIVE TRANSFER; ANIMALS; CARDIOVIRUS INFECTIONS; CD8-POSITIVE T-LYMPHOCYTES; DEMYELINATING DISEASES; EPITOPES, T-LYMPHOCYTE; MICE; T-LYMPHOCYTES, CYTOTOXIC; THEILOVIRUS; VIRAL LOAD;

EID: 77952577174     PISSN: 00426822     EISSN: 10960341     Source Type: Journal    
DOI: 10.1016/j.virol.2010.02.031     Document Type: Article

References (41)

1. Begolka W.S., Haynes L.M., Olson J.K., Padilla J., Neville K.L., Canto M.D., Palma J., Kim B.S., Miller S.D. CD8-deficient SJL mice display enhanced susceptibility to Theiler's virus infection and increased demyelinating pathology. J. Neurovirol. 2001, 7:409-420.
2. Borrow P., Tonks P., Welsh C.J.R., Nash A.A. The role of CD8+ T cells in the acute and chronic phases of Theiler's murine encephalomyelitis virus-induced disease in mice. J. Gen. Virol. 1992, 73:1861-1865.
3. Bruck W. The pathology of multiple sclerosis is the result of focal inflammatory demyelination with axonal damage. J. Neurol. 2005, 252(Suppl 5):v3-v9.
4. Bureau J.F., Drescher K.M., Pease L.R., Vikoren T., Delcroix M., Zoecklein L., Brahic M., Rodriguez M. Chromosome 14 contains determinants that regulate susceptibility to Theiler's virus-induced demyelination in the mouse. Genetics 1998, 148:1941-1949.
5. Clatch R.J., Miller S.D., Metzner R., Dal Canto M.C., Lipton H.L. Monocytes/macrophages isolated from the mouse central nervous system contain infectious Theiler's murine encephalomyelitis virus (TMEV). Virology 1990, 176:244-254.
6. Dudley M.E., Rosenberg S.A. Adoptive-cell-transfer therapy for the treatment of patients with cancer. Nat. Rev. 2003, 3:666-675.
7. Ercolini A.M., Miller S.D. The role of infections in autoimmune disease. Clin. Exp. Immunol. 2009, 155:1-15.
8. Fiette L., Aubert C., Brahic M., Pena Rossi C. Theiler's virus infection of beta2-microglobulin-deficient mice. J. Virol. 1993, 67:589-592.
9. Frey A.B., Monu N. Effector-phase tolerance: another mechanism of how cancer escapes antitumor immune response. J. Leukoc. Biol. 2006, 79:652-662.
10. Gattinoni L., Klebanoff C.A., Palmer D.C., Wrzesinski C., Kerstann K., Yu Z., Finkelstein S.E., Theoret M.R., Rosenberg S.A., Restifo N.P. Acquisition of full effector function in vitro paradoxically impairs the in vivo antitumor efficacy of adoptively transferred CD8+ T cells. J. Clin. Invest. 2005, 115:1616-1626.
11. + cytotoxic T cells. J. Virol. 2007, 81:6584-6593.
12. Goulder P.J., Altfeld M.A., Rosenberg E.S., Nguyen T., Tang Y., Eldridge R.L., Addo M.M., He S., Mukherjee J.S., Phillips M.N., Bunce M., Kalams S.A., Sekaly R.P., Walker B.D., Brander C. Substantial differences in specificity of HIV-specific cytotoxic T cells in acute and chronic HIV infection. J. Exp. Med. 2001, 193:181-194.
13. Haynes L.M., Vanderlugt C.L., Dal Canto M.C., Melvold R.W., Miller S.D. CD8+ T cells from Theiler's virus-resistant BALB/cByJ mice downregulate pathogenic virus-specific CD4+ T cells. J. Neuroimmunol. 2000, 106:43-52.
14. Jelachich M.L., Bandyopadhyay P., Blum K., Lipton H.L. Theiler's virus growth in murine macrophage cell lines depends on the state of differentiation. Virology 1995, 209:437-444.
15. Kang B.S., Lyman M.A., Kim B.S. The majority of infiltrating CD8+ T cells in the central nervous system of susceptible SJL/J mice infected with Theiler's virus are virus specific and fully functional. J. Virol. 2002, 76:6577-6585.
16. Letvin N.L. Progress and obstacles in the development of an AIDS vaccine. Nat. Rev. Immunol. 2006, 6:930-939.
17. Lipton H.L., Jelachich M.L. Molecular pathogenesis of Theiler's murine encephalomyelitis virus-induced demyelinating disease in mice. Intervirology 1997, 40:143-152.
18. Lyman M.A., Myoung J., Mohindru M., Kim B.S. Quantitative, not qualitative, differences in CD8(+) T cell responses to Theiler's murine encephalomyelitis virus between resistant C57BL/6 and susceptible SJL/J mice. Eur. J. Immunol. 2004, 34:2730-2739.
19. McMahon E.J., Bailey S.L., Castenada C.V., Waldner H., Miller S.D. Epitope spreading initiates in the CNS in two mouse models of multiple sclerosis. Nat. Med. 2005, 11:335-339.
20. McMichael A. T cell responses and viral escape. Cell 1998, 93:673-676.
21. Michel M.L., Mancini-Bourgine M. Therapeutic vaccination against chronic hepatitis B virus infection. J. Clin. Virol. 2005, 34(Suppl 1):S108-S114.
22. Miller S.D., Vanderlugt C.L., Begolka W.S., Pao W., Yauch R.L., Neville K.L., Katz-Levy Y., Carrizosa A., Kim B.S. Persistent infection with Theiler's virus leads to CNS autoimmunity via epitope spreading. Nat. Med. 1997, 3:1133-1136.
23. Munz C., Lunemann J.D., Getts M.T., Miller S.D. Antiviral immune responses: triggers of or triggered by autoimmunity?. Nat. Rev. Immunol. 2009, 9:246-258.
24. Murray P.D., Pavelko K.D., Leibowitz J., Lin X., Rodriguez M. CD4+ and CD8+ T cells make discrete contributions to demyelination and neurologic disease in a viral model of multiple sclerosis. J. Virol. 1998, 72:7320-7329.
25. Neville K.L., Padilla J., Miller S.D. Myelin-specific tolerance attenuates the progression of a virus-induced demyelinating disease: implications for the treatment of MS. J. Neuroimmunol. 2002, 123:18-29.
26. Nicholson S.M., Haynes L.M., Miller S.D., Melvold R.W. The role of protective CD8+ T cells in resistance of BALB/c mice to TMEV-induced demyelinating disease: regulatory vs. lytic. J. Neuroimmunol. 1999, 98:136-146.
27. Palma J.P., Lee H.G., Mohindru M., Kim B.S., Dal Canto M.C., Miller S.D., Kim B.S. Enhanced susceptibility to Theiler's virus-induced demyelinating disease in perforin-deficient mice. J. Neuroimmunol. 2001, 116:25-35.
28. Pullen L.C., Miller S.D., Dal Canto M.C., Kim B.S. Class I-deficient resistant mice intracerebrally inoculated with Theiler's virus show an increased T cell response to viral antigens and susceptibility to demyelination. Eur. J. Immunol. 1993, 23:2287-2293.
29. Qi Y., Dal C.M.C. Effect of Theiler's murine encephalomyelitis virus and cytokines on cultured oligodendrocytes and astrocytes. J. Neurosci. Res. 1996, 45:364-374.
30. Riddell S.R., Elliott M., Lewinsohn D.A., Gilbert M.J., Wilson L., Manley S.A., Lupton S.D., Overell R.W., Reynolds T.C., Corey L., Greenberg P.D. T-cell mediated rejection of gene-modified HIV-specific cytotoxic T lymphocytes in HIV-infected patients. Nat. Med. 1996, 2:216-223.
31. Rivera-Quinones C., McGavern D., Schmelzer J.D., Hunter S.F., Low P.A., Rodriguez M. Absence of neurological deficits following extensive demyelination in a class I-deficient murine model of multiple sclerosis. Nat. Med. 1998, 187-193.
32. Rodriguez M., David C.S. Demyelination induced by Theiler's virus: influence of the H-2 haplotype. J. Immunol. 1985, 135:2145-2148.
33. Rodriguez M., Leibowitz J., David C.S. Susceptibility to Theiler's virus-induced demyelination. Mapping of the gene within the H-2D region. J. Exp. Med. 1986, 163:620-631.
34. Rodriguez M., Dunkel A.J., Thiemann R.L., Leibowitz J., Zijlstra M., Jaenisch R. Abrogation of resistance to Theiler's virus-induced demyelination in H-2b mice deficient in beta2-microglobulin. J. Immunol. 1993, 151:266-276.
35. Sospedra M., Martin R. Immunology of multiple sclerosis. Annu. Rev. Immunol. 2005, 23:683-747.
36. Stroop W.G., Baringer J.R., Brahic M. Detection of Theiler's virus RNA in mouse central nervous system by in situ hybridization. Lab. Invest. 1981, 45:504-509.
37. Tompkins S.M., Padilla J., Dal Canto M.C., Ting J.P., Van Kaer L., Miller S.D. De novo central nervous system processing of myelin antigen is required for the initiation of experimental autoimmune encephalomyelitis. J. Immunol. 2002, 168:4173-4183.
38. Traugott U., Reinherz E.L., Raine C.S. Multiple sclerosis: distribution of T cell subsets within active chronic lesions. Science 1983, 219:308-310.
39. Walsh S.R., Bhardwaj N., Gandhil R.T. Dendritic cells and the promise of therapeutic vaccines for human immunodeficiency virus (HIV)-1. Curr. HIV Res. 2003, 1:205-216.
40. Walter E.A., Greenberg P.D., Gilbert M.J., Finch R.J., Watanabe K.S., Thomas E.D., Riddell S.R. Reconstitution of cellular immunity against cytomegalovirus in recipients of allogeneic bone marrow by transfer of T-cell clones from the donor. N. Engl. J. Med. 1995, 333:1038-1044.
41. Webster G., Bertoletti A. Quantity and quality of virus-specific CD8 cell response: relevance to the design of a therapeutic vaccine for chronic HBV infection. Mol. Immunol. 2001, 38:467-473.